StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SNTI

Senti Biosciences Holdings, Inc.

SNTI Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$0.37
+0.03 +8.53%

Key statistics

from XBRL data in SEC filings
Market cap
$11.5M
Revenue (TTM)
$22.0K
Net income (TTM)
-$51.5M
EPS (TTM)
$-1.46
P/E ratio
Dividend yield
Free cash flow
-$43.6M
Cash
$8.94M
Total assets
$38.2M
Gross margin
52-week range
$0.34 – $2.88

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Results of operations (earnings release); Change in control; Regulation FD disclosure; Other events Jul 15, 2026 8-K Entered a material agreement; Took on a direct financial obligation May 26, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release); Other events May 14, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Change in control May 1, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 29, 2026 8-K Other events Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release) Mar 27, 2026 8-K Entered a material agreement Mar 19, 2026 8-K Regulation FD disclosure; Other events Dec 9, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Director or officer change; Regulation FD disclosure Jul 18, 2025 8-K Shareholder vote results Jun 30, 2025 8-K Regulation FD disclosure; Other events Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Apr 28, 2025 8-K Entered a material agreement Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Director or officer change; Other events Mar 10, 2025 8-K Shareholder vote results Mar 7, 2025 8-K Director or officer change; Regulation FD disclosure Feb 25, 2025 8-K Director or officer change Feb 6, 2025 8-K Took on a direct financial obligation; Unregistered sale of equity; Other events Jan 6, 2025 8-K Other events Dec 16, 2024 8-K Other events Dec 3, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Other events Dec 2, 2024 8-K Regulation FD disclosure Dec 2, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Delisting notice or listing-rule failure Oct 25, 2024 8-K Entered a material agreement Sep 27, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release); Other events Aug 13, 2024 8-K Amended charter or bylaws Jul 17, 2024